Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$14.38 - $27.72 $726,190 - $1.4 Million
-50,500 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$9.23 - $19.67 $466,115 - $993,335
50,500 New
50,500 $968,000
Q2 2018

Aug 14, 2018

SELL
$12.0 - $19.88 $921,432 - $1.53 Million
-76,786 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$9.92 - $17.25 $761,717 - $1.32 Million
76,786 New
76,786 $1.03 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $449M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.